Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEFLAZACORT ORAL SUSPENSION safely and effectively. See full prescribing information for DEFLAZACORT ORAL SUSPENSION. DEFLAZACORT oral suspension Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
Deflazacort oral suspension is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
- generic_name
- deflazacort oral
- product_names
- Deflazacort Oral
- ndc
- 27808-249, 27808-249-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en